Cantabio Pharmaceuticals, Inc. Alternatives & Competitors
12 companies similar to Cantabio Pharmaceuticals, Inc. — Cantabio aim to slow, stop and even prevent the onset & progression of neurodege...
Companies similar to Cantabio Pharmaceuticals, Inc.
PharmaKure Limited
PharmaKure is a speciality biopharmaceutical company dedicated to the treatment of neurode...
Manchester, United Kingdo...
AFFiRiS AG
Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains....
Wien, Austria
ALSP, Inc.
Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative...
La Jolla, United States
Gain Therapeutics
Unfolding the next generation of allosteric small molecule therapies to meet patient needs...
Bethesda, United States
Track all Cantabio Pharmaceuticals, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Alector
We are on a mission to make brain disorders history.
South San Francisco, Unit...
Addex Therapeutics
Allosteric modulators for Human Health
Plan-les-ouates, Switzerl...
Merck & Co., Inc.
Merck develops and produces medicines, vaccines, biologic therapies and animal health prod...
BBB Therapeutics
Combines existing drugs with it's proprietary for enhanced drug delivery across the blood-...
Leiden, The Netherlands
Sharp Therapeutics
Developing small molecule drugs for genetic diseases..
Pittsburgh, United States
Astrocyte Pharmaceuticals
A Novel Approach to Neuroprotection
Groton, United States
Muna Therapeutics
Discovering and developing transformative therapeutics for neurodegenerative diseases
Denmark
Acadia Pharmaceuticals
Acadia is trailblazing breakthroughs in neuroscience to elevate life.
San Diego, United States
About Cantabio Pharmaceuticals, Inc.
Cantabio Pharmaceuticals, Inc. is a preclinical stage biotechnology company with a mission to slow, stop and even prevent the onset and progression of neurodegenerative diseases. Founded in 2009, the company focuses on commercializing novel therapies and intellectual property to combat Parkinson’s disease (PD), Alzheim...
Preclinical Stage, Therapies, Intellectual Property, Parkinson’s Disease, Alzheimer’s Disease, Neurodegenerative Diseases, Drug Discovery, Pharmacological Chaperones, Clinical Trials, Blood-brain Barrier, Therapeutic Proteins, Biophysics, Neuroscience
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Cantabio Pharmaceuticals, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Cantabio Pharmaceuticals, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
